Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer
Go back to Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer| (AMEX: SNANF) | Delayed: 0.21 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.21 | 52 Week High | $ | |||
| Open | $0.21 | 52 Week Low | $ | |||
| Day High | $0.21 | P/E | N/A | |||
| Day Low | $0.21 | EPS | $ | |||
| Volume | 12 | |||||



